pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 4·1 min read
save

Lawmakers backtrack on promised Medicaid protections for cancer patients, new CMS rules impose work requirements

Jun 4, 2026·read at STAT ↗RegulatoryNegative

Gwen Nichols, a hematologist/oncologist and chief medical officer of Blood Cancer United, wrote that lawmakers who pledged to protect cancer patients from Medicaid cuts are now backing a policy that could undermine that promise.

The Centers for Medicare & Medicaid Services is advancing work‑reporting requirements that would force states to verify enrollee work status every six months and demand at least 80 hours of community service, education or employment each month. For patients undergoing cancer treatment, meeting such a threshold is often impossible.

Advocates, including more than 160 blood‑cancer groups, have met with congressional staff to voice alarm. Many lawmakers were reportedly surprised by the potential impact on people with serious conditions, as the rule threatens to make essential health coverage harder to retain for low‑income patients.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise”

read at STAT ↗
1,309 words · retrieved Jun 4
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
JOURNEYUNIQUE
topics
Oncology30Hematology8

related stories

  • Sep 21Behind the outcomes: How whole-patient support is reshaping oncology careBioPharma Dive
  • 1d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Sep 7BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancerFierce Biotech
  • Sep 3‘Tactical athletes’ get new guidance for cardiovascular fitnessSTAT
  • Aug 26Flagship’s ProFound partners with Gates Foundation in $35M preeclampsia target discovery pactFierce Biotech